Successful treatment of brain tumors leads to a longer, better quality of life. At the Stanford Brain Tumor Center, our doctors are at the forefront of the latest, successful brain tumor diagnosis, treatment and clinical trials options.
Brain Tumor Center at the Neuroscience Clinic, Boswell Building
300 Pasteur Drive
Stanford, CA 94305
Researchers at Stanford are finding new treatments for brain tumors and rapidly converting them to safe clinical practice. People with brain tumors now have more hope for a good quality of life than ever before. This is especially true at Stanford where we are committed to healing our patients through science and compassion together.
Stanford researcher Albert J. Wong, MD, has discovered a variant of a normal receptor called EGFRvIII expressed only on tumors and not normal brain and created a vaccine targeting this abnormal receptor. This vaccine has moved through phase 2 clinical trials and a multicenter phase 3 clinical trial testing this vaccine is being planned.
Sharon Tong was unsure what to do when diagnosed with a meningioma. Compassionate staff at Stanford helped her choose a treatment plan that succeeded.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
HOW TO REFER
To refer a patient and schedule an appointment, call the Cancer Center New Patient Coordinator at 650-736-7440 or call the Neuroscience Clinic at 650-723-6469.